Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,775 | 638 | 89.1% |
| Consulting Fee | $1,337 | 2 | 9.3% |
| Education | $179.90 | 6 | 1.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $25.00 | 1 | 0.2% |
| Travel and Lodging | $16.08 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $2,710 | 63 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,024 | 87 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $1,775 | 68 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,405 | 118 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $966.00 | 46 | $0 (2024) |
| kaleo, Inc. | $593.45 | 25 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $506.79 | 38 | $0 (2024) |
| Genentech USA, Inc. | $505.39 | 17 | $0 (2024) |
| Octapharma USA, Inc. | $449.88 | 14 | $0 (2023) |
| CSL Behring | $436.72 | 16 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,907 | 121 | GENZYME CORPORATION ($1,703) |
| 2023 | $2,484 | 123 | Regeneron Healthcare Solutions, Inc. ($462.32) |
| 2022 | $2,174 | 92 | AstraZeneca Pharmaceuticals LP ($522.96) |
| 2021 | $1,227 | 58 | GlaxoSmithKline, LLC. ($216.53) |
| 2020 | $1,120 | 56 | Regeneron Healthcare Solutions, Inc. ($214.10) |
| 2019 | $972.90 | 57 | GENZYME CORPORATION ($214.24) |
| 2018 | $1,222 | 66 | Genentech USA, Inc. ($216.38) |
| 2017 | $1,225 | 75 | AstraZeneca Pharmaceuticals LP ($171.41) |
All Payment Transactions
648 individual payment records from CMS Open Payments — Page 1 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Cycle Pharmaceuticals Inc | Sajazir (Drug) | Food and Beverage | In-kind items and services | $8.94 | General |
| Category: IMMUNOLOGY | ||||||
| 12/18/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: Immunology | ||||||
| 12/13/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $5.96 | General |
| Category: RESPIRATORY | ||||||
| 12/10/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.89 | General |
| Category: Immunology | ||||||
| 12/09/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $6.43 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/04/2024 | BioCryst US Sales Co., LLC | ORLADEYO (Drug) | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: Immunology | ||||||
| 12/03/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $7.81 | General |
| Category: RESPIRATORY | ||||||
| 12/02/2024 | Hikma Pharmaceuticals USA | Ryaltris (Drug) | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 11/21/2024 | GENZYME CORPORATION | — | Consulting Fee | Cash or cash equivalent | $1,320.00 | General |
| 11/21/2024 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $166.02 | General |
| 11/21/2024 | GENZYME CORPORATION | — | Travel and Lodging | Cash or cash equivalent | $16.08 | General |
| 11/21/2024 | HOSPIRA, INC. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug), PANZYGA, CUTAQUIG | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $10.95 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/06/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $24.02 | General |
| Category: Immunology | ||||||
| 11/06/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.81 | General |
| Category: RESPIRATORY | ||||||
| 11/04/2024 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $6.78 | General |
| 10/29/2024 | Takeda Pharmaceuticals U.S.A., Inc. | CUVITRU (Biological) | Food and Beverage | In-kind items and services | $11.61 | General |
| Category: IMMUNOLOGY | ||||||
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: Respiratory | ||||||
| 10/23/2024 | Kedrion Biopharma, Inc. | Albuked (Biological), KOATE, GAMMAKED | Food and Beverage | Cash or cash equivalent | $19.92 | General |
| Category: Critical Care | ||||||
| 10/22/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Education | In-kind items and services | $76.27 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/22/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $7.66 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/18/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.52 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/15/2024 | Takeda Pharmaceuticals U.S.A., Inc. | CUVITRU (Biological) | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: IMMUNOLOGY | ||||||
| 10/15/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $7.04 | General |
| Category: Immunology | ||||||
| 10/08/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $10.23 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 536 | 11,123 | $324,135 | $118,383 |
| 2022 | 8 | 490 | 6,058 | $133,921 | $66,649 |
| 2021 | 8 | 402 | 4,626 | $102,718 | $57,161 |
| 2020 | 6 | 376 | 5,113 | $98,699 | $50,173 |
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J1306 | Injection, inclisiran, 1 mg | Office | 2023 | 17 | 5,396 | $185,245 | $50,333 | 27.2% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2023 | 84 | 2,515 | $50,300 | $30,667 | 61.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 95 | 120 | $20,300 | $10,792 | 53.2% |
| 95004 | Test for allergy using allergenic extract | Office | 2023 | 26 | 2,005 | $18,045 | $6,418 | 35.6% |
| 95117 | Professional service for multiple injections of allergen | Office | 2023 | 116 | 752 | $18,800 | $6,369 | 33.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 70 | 76 | $8,660 | $4,618 | 53.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 37 | 37 | $9,065 | $4,276 | 47.2% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 11 | 63 | $6,615 | $2,389 | 36.1% |
| 94375 | Test to measure rate of airflow | Office | 2023 | 46 | 57 | $3,135 | $1,658 | 52.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 23 | 59 | $3,110 | $563.94 | 18.1% |
| 95115 | Professional service for single injection of allergen | Office | 2023 | 11 | 43 | $860.00 | $298.80 | 34.7% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2022 | 80 | 2,400 | $47,540 | $30,245 | 63.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 94 | 116 | $19,285 | $10,245 | 53.1% |
| 95004 | Test for allergy using allergenic extract | Office | 2022 | 33 | 2,541 | $22,869 | $8,087 | 35.4% |
| 95117 | Professional service for multiple injections of allergen | Office | 2022 | 118 | 775 | $19,375 | $6,586 | 34.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 48 | 48 | $11,580 | $5,628 | 48.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 64 | 67 | $7,495 | $3,807 | 50.8% |
| 94375 | Test to measure rate of airflow | Office | 2022 | 36 | 45 | $2,475 | $1,338 | 54.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 17 | 66 | $3,302 | $713.56 | 21.6% |
| 95165 | Preparation and provision of single or multiple antigens for allergen immunotherapy | Office | 2021 | 71 | 2,135 | $38,430 | $27,615 | 71.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 78 | 100 | $14,095 | $8,921 | 63.3% |
| 95117 | Injection of incremental dosages of allergen, 2 or more injections | Office | 2021 | 122 | 973 | $24,325 | $8,191 | 33.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 63 | 70 | $6,410 | $4,315 | 67.3% |
| 95004 | Injection of allergenic extracts into skin, accessed through the skin | Office | 2021 | 17 | 1,235 | $11,115 | $4,179 | 37.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 20 | 20 | $4,000 | $2,428 | 60.7% |
About Dr. Seth Hollander, M.D
Dr. Seth Hollander, M.D is a Internal Medicine healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/29/2007. The National Provider Identifier (NPI) number assigned to this provider is 1255451886.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Seth Hollander, M.D has received a total of $14,333 in payments from pharmaceutical and medical device companies, with $3,907 received in 2024. These payments were reported across 648 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($12,775).
As a Medicare-enrolled provider, Hollander has provided services to 1,804 Medicare beneficiaries, totaling 26,920 services with total Medicare billing of $292,366. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Allergy & Immunology
- Location Austin, TX
- Active Since 03/29/2007
- Last Updated 11/28/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1255451886
Products in Payments
- DUPIXENT (Biological) $2,707
- CUVITRU (Biological) $844.91
- TEZSPIRE (Biological) $809.05
- TRELEGY ELLIPTA (Drug) $638.63
- NUCALA (Biological) $628.38
- FASENRA (Biological) $557.35
- Xolair (Biological) $505.39
- AUVI-Q (Drug) $487.84
- XOLAIR (Biological) $484.98
- FASENRA (Drug) $341.88
- TAKHZYRO (Biological) $300.45
- CUTAQUIG (Biological) $272.20
- Hizentra (Biological) $272.19
- EUCRISA (Drug) $233.68
- ORLADEYO (Drug) $227.19
- SYMBICORT (Drug) $209.05
- DUPIXENT (Drug) $191.03
- RUCONEST (Biological) $170.44
- Haegarda (Biological) $164.53
- CINRYZE (Drug) $147.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Austin
Dr. Andrew Brenner, M.d., Ph.d, M.D., PH.D
Internal Medicine — Payments: $126,872
John Dallas, Md, MD
Internal Medicine — Payments: $94,461
Omesh Verma, Md, MD
Internal Medicine — Payments: $93,276
Lindsay Harrison, Md, MD
Internal Medicine — Payments: $80,623
Dr. Steven Berkowitz, Md, MD
Internal Medicine — Payments: $79,153
Dr. Manoj Thangam, M.d, M.D
Internal Medicine — Payments: $76,243